Original article
Applicability and validation of different prognostic scores in allogeneic hematopoietic cell transplant (HCT) in the post-transplant cyclophosphamide era
María Queralt Salasa,
, Luis Gerardo Rodríguez-Lobatoa,b,*, Paola Charrya, Maria Suárez-Lledóa,b,d, Alexandra Pedrazaa, María Teresa Solanoa, Jordi Arcaronsa, Joan Cida,b,c, Miquel Lozanoa,c,d, Laura Rosiñola,b,d, Jordi Estevea,b,d, Enric Carrerasc, Francesc Fernández-Avilésa,b,d, Carmen Martíneza,b,c,d, Montserrat Roviraa,b,c,d
Autor para correspondência
Queralt.salas87@outlook.es
Corresponding author at: Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology-Oncology (ICHMO), Hospital Clínic de Barcelona, C/ Vilarroel 190, CP 08036, Spain.
Corresponding author at: Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology-Oncology (ICHMO), Hospital Clínic de Barcelona, C/ Vilarroel 190, CP 08036, Spain.
a Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
b Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
c Josep Carreras Leukemia Research Institute (Clinic Campus), Barcela, Spain
d University of Barcelona, Barcelona, Spain
Lido
1826
Vezesque se leu este artigo
497
Total PDF
1329
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 40 | 6 | 46 |
| 2025 5 | 90 | 7 | 97 |
| 2025 4 | 82 | 17 | 99 |
| 2025 3 | 74 | 9 | 83 |
| 2025 2 | 60 | 30 | 90 |
| 2025 1 | 59 | 17 | 76 |
| 2024 12 | 50 | 19 | 69 |
| 2024 11 | 67 | 17 | 84 |
| 2024 10 | 66 | 15 | 81 |
| 2024 9 | 77 | 25 | 102 |
| 2024 8 | 80 | 30 | 110 |
| 2024 7 | 69 | 44 | 113 |
| 2024 6 | 73 | 31 | 104 |
| 2024 5 | 71 | 31 | 102 |
| 2024 4 | 60 | 16 | 76 |
| 2024 3 | 58 | 35 | 93 |
| 2024 2 | 30 | 18 | 48 |
| 2024 1 | 41 | 19 | 60 |
| 2023 12 | 33 | 30 | 63 |
| 2023 11 | 97 | 44 | 141 |
| 2023 10 | 52 | 37 | 89 |
Mostrar tudo
